Three new drugs added to Cancer Drugs Fund will treat 900 patients a year
Nine hundred cancer patients every year could benefit from three new drugs which have been added to the Cancer Drugs Fund. The drugs Albumin Bound Paclitaxel, Bevacizumab and Cabozantinib are to be used to treat pancreatic cancer, brain tumours in children and thryroid cancer respectively. Albumin Bound Paclitaxel(this document is no longer available here but […]